Filing Details

Accession Number:
0001321732-18-000142
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-06 17:40:28
Reporting Period:
2018-12-03
Accepted Time:
2018-12-06 17:40:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1321732 Penumbra Inc PEN Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1704713 Bridget O'rourke One Penumbra Place
Alameda CA 94502
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-03 200 $139.65 3,650 No 4 S Direct
Common Stock Disposition 2018-12-03 100 $140.79 3,550 No 4 S Direct
Common Stock Disposition 2018-12-03 400 $141.64 3,150 No 4 S Direct
Common Stock Disposition 2018-12-03 100 $142.87 3,050 No 4 S Direct
Common Stock Disposition 2018-12-03 200 $143.55 2,850 No 4 S Direct
Common Stock Disposition 2018-12-03 200 $144.84 2,650 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $139.25 to $140.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. A portion of these shares is subject to vesting.
  4. This transaction was executed in multiple trades at prices ranging from $141.28 to $142.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $143.50 to $143.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $144.79 to $144.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.